HHS and VA Memorandum Could Benefit Psychedelic Drug Developers
A memorandum of understanding between HHS and the Veterans Administration aims to enhance collaboration on psychedelic-based treatments for veteran mental health. This development could support companies in this sector by potentially accelerating research, clinical trials, and deployment.
